It is possible to measure a variety of parameters from whole blood samples using blood gas analyzers and electrolyte analyzers. It is a measure of the equilibrium between the kidney, blood, and lungs. pCO2 of arterial blood is used to determine the efficiency of carbon dioxide removal from the body. However, oxygen absorption is measured by the pO2 value of arterial blood, which is a by-product of metabolism. More about the body's metabolism may be learned from its metabolites and electrolytes
The blood gas analyzers market is also growing due to the increase in the number of patients being treated in neonatal intensive care units, intensive care units (ICU), and emergency rooms (ED). The market for blood gas and electrolyte analyzers is also growing due to an increase in patients with chronic illnesses and cancer. A key driver of the growth of the blood gas and electrolyte analyzers market is technological advancements and a rise in product approvals. However, the complexity of interpreting blood analysis data is a hindrance to the market's growth.
Blood gas testing and point-of-care (POC) diagnostic assessment are required more frequently as people age, which is expected to drive the blood gas and electrolyte market upwards. According to the World Health Organization, chronic diseases caused 3 million deaths in 2015, or 5% of all deaths worldwide. This has led to a significant increase in emergency cases, which has led to a huge need for blood gas and electrolyte analyzers.
Approximately three-quarters of chronic illnesses occur in low- and middle-income nations because they lack the major integrated systems for early diagnosis and treatment that individuals in high-income countries enjoy. The greatest blood gas electrolyte market is found in the most populous urbanized region, such as North America, which relies on medical breakthroughs for treatment.